Currently browsing tag


U.S. jury clears Pfizer in second trial over Zoloft

By Jessica Dye NEW YORK (Reuters) – A U.S. jury on Thursday said Pfizer Inc was not responsible for birth defects in a young girl whose mother took its antidepressant Zoloft while pregnant, the second straight win for the company out of hundreds of similar lawsuits. Plaintiff Rachel Robinson claimed in her 2011 lawsuit that Pfizer failed to warn that using Zoloft during pregnancy could cause birth defects and sought damages from the company after her now eight-year-old daughter was born with a rare, serious heart problem. Following a week-and-a-half long trial in state court in Philadelphia, jurors on Thursday returned a verdict for the company, according to Pfizer spokeswoman Neha Wadhwa.